Earnings call transcript: SPS Commerce Q2 2025 beats forecasts, stock dips

SPS Commerce (SPSC) reported robust Q2 2025 results, with EPS of $1.00 and revenue of $187.4 million both exceeding analyst forecasts, driven by 24% recurring revenue growth and a 27% increase in adjusted EBITDA. Despite this strong performance, the stock declined 0.39% in after-hours trading, attributed to elevated valuation multiples and broader macroeconomic concerns, including heightened supplier spending scrutiny, particularly in the U.S. Looking ahead, SPS Commerce projects full-year 2025 revenue between $759-$763 million and anticipates at least high single-digit organic revenue growth beyond 2025, alongside annual adjusted EBITDA margin expansion, underscoring its resilient SaaS model and ongoing M&A strategy amidst these headwinds.

Analysis

SPS Commerce (SPSC) delivered a robust second quarter for 2025, exceeding analyst expectations with an EPS of $1.00 against a $0.91 forecast and revenue of $187.4 million, slightly above the $185.82 million consensus. This performance was underpinned by strong fundamentals, including a 22% year-over-year revenue increase, 24% growth in recurring revenue, and a 27% rise in adjusted EBITDA. Despite these positive results, the stock experienced a minor 0.39% decline in after-hours trading. This muted market reaction appears to be driven by two primary factors: elevated valuation multiples, with a P/E ratio of 64.2, and a cautious forward-looking outlook. Management has guided for organic revenue growth to moderate to "at least high single digits" beyond 2025, a notable deceleration from the 19-20% total growth projected for the full year 2025. This slowdown is attributed to macroeconomic headwinds, specifically heightened spending scrutiny and delayed purchasing decisions among its U.S. mid-market supplier customers. This caution is echoed by the fact that eight analysts have recently revised earnings expectations downward for the upcoming period. The company's strategy continues to rely on disciplined M&A for supplemental growth and a commitment to expand adjusted EBITDA margins by 200 basis points annually, which provides a partial offset to the moderating organic top-line forecast.

Key Decisions for Investors

• Investors should recalibrate long-term models to reflect the new post-2025 organic revenue growth guidance of 'high single digits', a significant deceleration from the current M&A-inclusive growth rate.
• Monitor leading indicators of U.S. mid-market supplier health and spending, as management has explicitly linked the cautious outlook to delayed purchasing decisions in this segment.
• Given the stock's high valuation multiples, the new, lower organic growth profile may not be fully priced in, suggesting potential for valuation compression until macroeconomic uncertainty subsides.
• Focus on the company's ability to execute its M&A strategy and achieve its targeted 200 basis point annual adjusted EBITDA margin expansion, as these will be critical drivers of shareholder value amid slowing organic growth.